FASTER, PLEASE: A stealthy Harvard startup wants to reverse aging in dogs, and humans could be next. Why start with dogs? “Dogs are a market in and of themselves. It’s not just a big organism close to humans. It’s something people will pay for, and the FDA process is much faster. We’ll do dog trials, and that’ll be a product, and that’ll pay for scaling up in human trials.”